137 related articles for article (PubMed ID: 18791686)
1. Serum levels of angiogenic cytokines decrease after radiotherapy in non-Hodgkin lymphomas.
Ria R; Cirulli T; Giannini T; Bambace S; Serio G; Portaluri M; Ribatti D; Vacca A; Dammacco F
Clin Exp Med; 2008 Sep; 8(3):141-5. PubMed ID: 18791686
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy.
Ria R; Portaluri M; Russo F; Cirulli T; Di Pietro G; Bambace S; Cucci F; Romano T; Vacca A; Dammacco F
Cancer Lett; 2004 Dec; 216(1):103-7. PubMed ID: 15500953
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma.
Etto L; Lacerda E; Baiocchi O; Silva V; Dalboni M; Alves A; Silva M; Vettore A; Colleoni G
Leuk Lymphoma; 2008 Feb; 49(2):257-64. PubMed ID: 18231911
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
6. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran.
Shamsdin SA; Mehrafshan A; Rakei SM; Mehrabani D
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2883-2890. PubMed ID: 31653130
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
[TBL] [Abstract][Full Text] [Related]
9. Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.
Saltarella I; Morabito F; Giuliani N; Terragna C; Omedè P; Palumbo A; Bringhen S; De Paoli L; Martino E; Larocca A; Offidani M; Patriarca F; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Grasso M; Leonardi G; Rizzo M; Falcone AP; Gottardi D; Montefusco V; Musto P; Petrucci MT; Dammacco F; Boccadoro M; Vacca A; Ria R
J Hematol Oncol; 2019 Jan; 12(1):4. PubMed ID: 30626425
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
12. Correlation between increasing tissue ischemia and circulating levels of angiogenic growth factors in peripheral artery disease.
Jalkanen J; Hautero O; Maksimow M; Jalkanen S; Hakovirta H
Cytokine; 2018 Oct; 110():24-28. PubMed ID: 29689451
[TBL] [Abstract][Full Text] [Related]
13. [Effects of fibroblast growth factor-10 on the secretions of transforming growth factor-alpha, platelet-derived growth factor-AB and vascular endothelial growth factor by normal adult human keratinocytes in culture].
Sun XQ; Fu XB; Chen W; Sun TZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):13-8. PubMed ID: 14706196
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
[TBL] [Abstract][Full Text] [Related]
16. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders.
Laddha AP; Kulkarni YA
Respir Med; 2019 Sep; 156():33-46. PubMed ID: 31421589
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
18. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.
Iwasaki T; Hamano T; Ogata A; Hashimoto N; Kitano M; Kakishita E
Br J Haematol; 2002 Mar; 116(4):796-802. PubMed ID: 11886383
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiogenic growth factor combinations on retinal endothelial cells.
Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
